Weight loss and metabolic health markers Beyond the scale, retatrutide produced improvements in virtually every metabolic health marker measured
The study can inform policy changes that expand insurance coverage for GLP-1 drugs across a wider range of insurance plans, employment industries, income levels, sex, and other factors
GLP-1 RA therapy should be discontinued under specific clinical conditions to minimize risk
Impact on Eating Disorders: While primarily used for weight management, GLP-1s might have a complex role to play in eating disorders
Be sure to talk to your healthcare professional about the best protocol for you
Semaglutide injection and CV impact was evaluated using the SUSTAIN-6 trial (designed as a non-inferiority trials), which primarily showed a reduction in the rate of non-fatal stroke events (RR 0.61